SLC1A2 and amyotrophic lateral sclerosis: Initial evidence for an astrocyte contribution to ALS came from studies of humans [12], [13] and rodent ALS models [6] indicating dysfunction and large decreases in levels of the primary astrocyte glutamate transporter, GLT1 (EAAT2 in human), in areas of motor neuron loss.